FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057867 [Registered on: 20/09/2023] Trial Registered Prospectively
Last Modified On: 18/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A comparative study of the importance of two-dimensional Echocardiography in Hypertensive disorders of pregnancy (HDP) and normal pregnant women, as well as its effect on maternal and fetal outcome.  
Scientific Title of Study   "A prospective comparative study of significance of two-Dimensional Echocardiography in Hypertensive disorders of pregnancy (HDP) compared to normal pregnancy and its effect on Fetomaternal outcomes".  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DRMADDERLA SOWMYA 
Designation  JUNIOR RESIDENT (PG) 
Affiliation  SHRI BM PATIL MEDICAL COLLEGE 
Address  OBG OPD NO2 DEPT OF OBG SHRI BM PATIL MEDICAL COLLEGEHOSPITAL AND RESEARCH CENTRE, BANGARAMMA SAJJAN CAMPUS, SOLAPUR ROAD, VIJAYAPURA-586103

Bijapur
KARNATAKA
586103
India 
Phone  8309400654  
Fax    
Email  sowmya.madderla@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DRSHREEDEVI KORI 
Designation  ASSOCIATE PROFESSOR 
Affiliation  SHRI BM PATIL MEDICAL COLLEGE 
Address  OBG OPD NO2 DEPT OF OBG SHRI BM PATIL MEDICAL COLLEGEHOSPITAL AND RESEARCH CENTRE, BANGARAMMA SAJJAN CAMPUS, SOLAPUR ROAD, VIJAYAPURA-586103

Bijapur
KARNATAKA
586103
India 
Phone  9113896750  
Fax    
Email  shree_kori@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DRSHREEDEVI KORI 
Designation  ASSOCIATE PROFESSOR 
Affiliation  SHRI BM PATIL MEDICAL COLLEGE 
Address  OBG OPD NO2 DEPT OF OBG SHRI BM PATIL MEDICAL COLLEGEHOSPITAL AND RESEARCH CENTRE, BANGARAMMA SAJJAN CAMPUS, SOLAPUR ROAD, VIJAYAPURA-586103

Bijapur
KARNATAKA
586103
India 
Phone  9113896750  
Fax    
Email  shree_kori@yahoo.com  
 
Source of Monetary or Material Support  
SHRI B.M PATIL MEDICAL COLLEGE 
 
Primary Sponsor  
Name  Shri BM Patil medical college and hospital  
Address  OBG OPD NO2 DEPT OF OBG SHRI BM PATIL MEDICAL COLLEGEHOSPITAL AND RESEARCH CENTRE, BANGARAMMA SAJJAN CAMPUS, SOLAPUR ROAD, VIJAYAPURA-586103 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DRMADDERLA SOWMYA  SHRI BM PATIL MEDICAL COLLEGE HOSPITAL  OBG OPD NO.2 ,DEPT OF OBG .
Bijapur
KARNATAKA 
08309400654

sowmya.madderla@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE, BLDE (DEEMED TO BE UNIVERSITY), VIJAYAPURA.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O141||Severe pre-eclampsia, (2) ICD-10 Condition: O169||Unspecified maternal hypertension,unspecified trimester,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Women with a normal singleton pregnancy from 28 weeks to 42weeks period of gestation.
Women with gestational hypertension (BP≥140/90mmHg after 20 weeks of pregnancy) from 28
weeks to 42 weeks period of gestation.
Women with mild preeclampsia (gestational hypertension with proteinuria)
Women with severe preeclampsia (gestational hypertension with proteinuria with end-organ
damage)
Women with imminent eclampsia (preeclampsia with imminent signs) from 28 weeks to 42 weeks
period of gestation. 
 
ExclusionCriteria 
Details  Women who are not consenting to the study.
Women with chronic hypertension.
Women with eclampsia.
Women with Gestational age less than 28 weeks.
Women in active labor.
Multiple pregnancy, severe anemia patients.
Known cardiac disease (e.g., structural heart disease, coronary heart disease, cardiomyopathies, etc.
Connective tissue disorders.
Renal impairment.
Diabetes mellitus 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To know the two dimensional echocardiographic changes in pregnant women with HDPs compared to normal pregnant women.

 
24hours

 
 
Secondary Outcome  
Outcome  TimePoints 
To analyze the correlation between Echocardiographic abnormalities and fetomaternal outcome of pregnant women with HDPs compared to that of normal pregnant women.
 
24hours 
 
Target Sample Size   Total Sample Size="142"
Sample Size from India="142" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

1)     All singleton pregnant women from 28 weeks to 42weeks gestation meeting the inclusion criteria will be screened for hypertension by measuring their blood pressure using a standard auscultatory method with the help of a mercury sphygmomanometer. Systolic and diastolic blood pressure will be measured in the sitting position in the right arm at the level of the heart.6 Heart rate is measured along with mean arterial pressure.

2)     The patients who are normotensive will be divided into one group who will be serving as controls, and a departmental ECHO will be done.

3)      The patients who will show B.P.> 140/90mmHg on two occasions 4hrs apart will be considered hypertensive and will be divided into another group serving as cases.

4)     Bed side urine albumin test done by taking 2ml urine with 2ml of sulphosalicylic acid added and checked for cloudiness to differentiate gestational hypertension with preeclampsia and as a routine protocol, all basic investigations and departmental ECHO will be done.

4)     In patients who are in early pregnancy (28weeks to 32weeks), again repeat 2DECHO will be done near term.

5)     Data will be compared in terms of echocardiographic findings and structural anomalies on echocardiography in normal pregnant women with HDPs.

6)     Data will also be compared in terms of complications of maternal outcomes like Congestive Cardiac Failure(C.C.F.), Atrial fibrillation, hypertensive crisis, cardiomyopathy, Intensive Care Unit(I.C.U.)  admissions, maternal mortality, and complications of fetal outcomes like Intra Uterine Growth Retardation(I.U.G.R.), preterm, Neonatal Intensive care Unit (NICU) admissions, Intra Uterine Deaths.

A cardiologist’s opinion will be taken in patients with abnormal echocardiographic findings, and a decision regarding the plan of treatment will be taken.

 

 
Close